000303216 001__ 303216
000303216 005__ 20250730114249.0
000303216 0247_ $$2doi$$a10.1002/cam4.71074
000303216 0247_ $$2pmid$$apmid:40714912
000303216 0247_ $$2pmc$$apmc:PMC12296696
000303216 037__ $$aDKFZ-2025-01567
000303216 041__ $$aEnglish
000303216 082__ $$a610
000303216 1001_ $$0P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6$$aKias, Alina$$b0$$eFirst author$$udkfz
000303216 245__ $$aFactors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.
000303216 260__ $$aHoboken, NJ$$bWiley$$c2025
000303216 3367_ $$2DRIVER$$aarticle
000303216 3367_ $$2DataCite$$aOutput Types/Journal article
000303216 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753794901_3434
000303216 3367_ $$2BibTeX$$aARTICLE
000303216 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303216 3367_ $$00$$2EndNote$$aJournal Article
000303216 500__ $$a#EA:C110#LA:C110#
000303216 520__ $$aAs survival of patients with metastatic breast cancer (MBC) improves, their work situation is gaining importance. The aim of the current study was to identify factors associated with work status and quality of working life (QWL) in patients with MBC. Additionally, we investigated the effects of an exercise intervention on work status.Within the multinational PREFERABLE-EFFECT exercise trial, 287 patients with MBC of working age (18-65 years) reported on their working situation over 9 months as a secondary endpoint. Among a subgroup of participants, QWL was assessed by the Quality of Working Life Questionnaire for Cancer Survivors (QWLQ-CS) (N = 59).At baseline, 157 (54.7%) participants were employed, of whom one-third reported having recently reduced their amount of work because of fatigue (41.7%), cognitive problems (33.3%), or inability to meet work demands (33.3%). Participants wished for more flexible working hours (29.2%) and less productivity pressure (37.5%). Participants were less likely to work if they experienced higher levels of pain (p = 0.014). Among working participants, an academic education and higher levels of psychological distress were associated with a higher number of working hours (all p < 0.05). Fatigue, an academic education, and performing mentally strenuous tasks at work were negatively associated with QWL (all p < 0.05). The exercise intervention did not affect the number of hours worked during the study.Symptom management might be important for patients' ability to work. To help patients stay employed and improve QWL, employers should consider offering more flexible work arrangements and adapting to their employees' changing needs and abilities.The PREFERABLE-EFFECT trial was registered with ClinicalTrials.gov on October 9, 2019 (NCT04120298).
000303216 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000303216 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303216 650_7 $$2Other$$aemployment
000303216 650_7 $$2Other$$aexercise
000303216 650_7 $$2Other$$afatigue
000303216 650_7 $$2Other$$ametastatic breast cancer
000303216 650_7 $$2Other$$apain
000303216 650_7 $$2Other$$aquality of working life
000303216 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b1$$udkfz
000303216 7001_ $$00000-0002-6216-2609$$aHiensch, Anouk E$$b2
000303216 7001_ $$0P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aClauss, Dorothea$$b3$$udkfz
000303216 7001_ $$aMonninkhof, Evelyn M$$b4
000303216 7001_ $$00000-0001-8022-4925$$aPelaez, Mireia$$b5
000303216 7001_ $$aBelloso, Jon$$b6
000303216 7001_ $$00009-0008-5847-7086$$aGunasekara, Nadira$$b7
000303216 7001_ $$00000-0003-4892-4061$$aSweegers, Maike G$$b8
000303216 7001_ $$00000-0002-9078-0180$$aTrevaskis, Mark$$b9
000303216 7001_ $$00000-0002-5617-9076$$aRundqvist, Helene$$b10
000303216 7001_ $$aMüller, Jana$$b11
000303216 7001_ $$aWiskemann, Joachim$$b12
000303216 7001_ $$avan der Wall, Elsken$$b13
000303216 7001_ $$aAaronson, Neil K$$b14
000303216 7001_ $$00000-0002-8402-0564$$aLachowicz, Milena$$b15
000303216 7001_ $$00000-0003-0359-3641$$aUrruticoechea, Ander$$b16
000303216 7001_ $$00000-0001-6250-0041$$aZopf, Eva M$$b17
000303216 7001_ $$aBloch, Wilhelm$$b18
000303216 7001_ $$00000-0002-7794-7767$$aStuiver, Martijn M$$b19
000303216 7001_ $$00000-0001-8317-7829$$aWengström, Yvonne$$b20
000303216 7001_ $$00000-0003-0643-3790$$aMay, Anne M$$b21
000303216 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b22$$eLast author$$udkfz
000303216 773__ $$0PERI:(DE-600)2659751-2$$a10.1002/cam4.71074$$gVol. 14, no. 15, p. e71074$$n15$$pe71074$$tCancer medicine$$v14$$x2045-7634$$y2025
000303216 909CO $$ooai:inrepo02.dkfz.de:303216$$pVDB
000303216 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000303216 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000303216 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000303216 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000303216 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000303216 9141_ $$y2025
000303216 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-07$$wger
000303216 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER MED-US : 2022$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-08T17:04:21Z
000303216 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-08T17:04:21Z
000303216 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-08-08T17:04:21Z
000303216 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-08-08T17:04:21Z
000303216 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-07
000303216 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-07
000303216 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Krebsprävention und Survivorship$$x0
000303216 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Krebsprävention und Survivorship$$x0
000303216 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Krebsprävention und Survivorship$$x0
000303216 980__ $$ajournal
000303216 980__ $$aVDB
000303216 980__ $$aI:(DE-He78)C110-20160331
000303216 980__ $$aUNRESTRICTED